Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
Rhea-AI Summary
Lifeward (Nasdaq: LFWD) will report fourth quarter and full year 2025 financial results before markets open on March 18, 2026. A live conference call and webcast with CEO Mark Grant and CFO Almog Adar begins at 8:30 a.m. EST. An archived webcast will be available on the Investors Events Calendar.
Positive
- None.
Negative
- None.
News Market Reaction – LFWD
In the Mar 11 session, LFWD gained 5.20%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Nov 10 | Earnings date notice | Neutral | +4.1% | Announced Q3 2025 results date and earnings call details with management. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
The prior earnings-date announcement was followed by a positive 4.08% move, indicating historically constructive reactions to earnings scheduling updates.
Over the past several months, Lifeward has used earnings-date press releases to flag upcoming financial disclosures and conference calls. On Nov 10, 2025, it announced third quarter 2025 results timing with similar dial-in details, and the stock moved 4.08% over the next day. Today’s fourth quarter and full-year 2025 earnings-date announcement follows the same pattern, signaling continuity in communication practices without adding new financial metrics.
Key Terms
earnings call financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its fourth quarter and full year 2025 financial results before the markets open on Wednesday, March 18, 2026.
Mark Grant, President and Chief Executive Officer, and Almog Adar, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EST to discuss the financial results. To access the call, analysts and investors may utilize the following:
| Toll free (U.S.) | 1-833-316-0561 |
| International (U.S) | 1-412-317-0690 |
| Germany | 0800-6647650 |
| Israel | 1-80-9212373 |
| Access Code | Please reference the “Lifeward Earnings Call” |
The conference call will be webcast live and can be accessed through a link on the Company’s website at golifeward.com in the "Investors" section, or through the following link: https://edge.media-server.com/mmc/p/yc9qmwr7. An archived webcast will also be available on the Company's website at the Investor Events Calendar page.
About Lifeward
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit.
Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward mission and product portfolio, please visit GoLifeward.com.
Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.
Contact:
Almog Adar
Chief Financial Officer
Lifeward
E: media@golifeward.com
E: ir@golifeward.com
